Core Faculty

I have completed my internal medicine residency training at the NYP/Weill-Cornell, New York, and fellowship in Infectious diseases/HIV at the Massachusetts General Hospital and Brigham and Women's Hospital, Harvard University, Boston. Prior to that, I did a PhD at the Kirby Institute/University of New South Wales (Australia) in epidemiological studies in HIV/AIDS. Some of my notable work has focused on impact of BMI and weight gain from antiretroviral therapy on diabetes and cardiovascular outcomes; dual-drug therapies for HIV/AIDS; inflammatory markers and clinical outcomes in HIV; and implementation research on improving HIV treatment outcomes in Asia-Pacific, amongst others. Clinically, I'm interested in HIV primary care, cases of HIV with complex resistance history, STIs, COVID-19 therapeutics, and general infectious diseases.

Dr. Dunne has spent the majority of her career focusing on the care of patients with sexually transmitted diseases and on the education of clinicians who also care for these patients. She is a founding and core faculty member for the Yale Primary Care HIV Training Track.Dr Dunne also enjoys medical education and faculty development. She was the Inpatient Internal Medicine Clerkship Director from 2011-2023 and now is Director of the YMS Coaching program. She directs educator development projects for GME and UME.

Dr. Green received his medical degree from the University of North Carolina School of Medicine and Master of Science in Health Policy and Management from Harvard School of Public Health. His post graduate training included an internship, residency, and fellowship in general medicine at the Beth Israel Hospital in Boston and Harvard Medical School. Dr Green is Professor of Medicine and Director of Student Assessment at the Teaching and Learning Center at the Yale School of Medicine.  He serves on the steering committee of the AAMC Core EPAs for Entering Residency national pilot. He previously served on the ACGME / ABIM milestones task force and the SGIM reforming internal medicine residency training task force. Dr. Green's research interests include assessment, entrustable professional activities, retrieval-based learning, and evidence-based medicine.  He received the regional and national awards for scholarship in medical education from the Society of General Internal Medicine and was selected as a Kimball Scholar at the American Board of Internal Medicine. Dr Green cares for persons living with HIV infection and supervises medical residents at the Nathan Smith Clinic.

Being in love with medicine, people, and social movements, Dr. Augie Lindmark seeks to understand why some people have health care, why some don’t, and who gets to decide.Augie earned his medical degree from the University of Minnesota and completed an Oryema Fellowship in Social Medicine, where his research and writing focused on the sociopolitical roots of health—specifically, health system structures and the Right to Health movement.   In the clinical setting, Augie is an internal medicine physician at Yale New Haven Hospital with a focus on primary care and HIV medicine. He is also a resident physician in the Yale Primary Care program. Augie has been featured on various media outlets including The Washington Post, The Guardian, Pacific Standard, and The Correspondent, among others. His passion for storytelling and narrative medicine has appeared on multiple platforms including WordSprout and The Moth. He continues to write on the topics of public health, health inequities, and the role of organizing in medicine. You can find him on Twitter @AugieLindmark.

I am an Associate Professor of Medicine, in the clinician-educator track and Director of the Yale antivirals and Vaccines research program (formerly HIV Clinical Trials program) of the Yale AIDS Program, Section of Infectious Diseases of the Yale School of Medicine. My clinical responsibilities include educating and training medical students, residents and infectious diseases fellows in various capacities in inpatient and outpatient settings; and through structured course work and other teaching sessions. As a faculty of the HIV training track of the Yale-Internal Medicine primary care program and as a faculty of the Human Resources for Health program in Rwanda (2013 to 2019), I have extensive experience with curriculum development, structuring of residency training programs, and mentoring residents and faculty. In Rwanda specifically, I have and still continue to mentor medical residents and junior faculty in quality improvement and clinical research projects that are locally relevant and addressing important infectious diseases-related problems (particularly HIV/AIDS epidemic and antimicrobial resistance). Furthermore, I have facilitated meaningful educational and research collaborations between faculty and trainees across institutions. As the program director of World Bank and HRSA-funded efforts supporting the Liberia College of Physicians and surgeons (LCPS)–run Internal medicine residency training program, I have overseen the selection and deployment of faculty to Liberia, and am responsible for educational programs and activities aimed at strengthening the residency training program. Through an award from National Academy of Sciences / USAID, I have trained Liberia's first-ever Infectious Diseases physician who achieved fellowship of the West African College of Physicians in that specialty in 2022. Overall, my expertise and collective experiences to date have positioned me to design and run successful projects around capacity building in low-resource settings including developing and implementing innovative and robust medical training and research programs for faculty, fellows, residents and students. Since 2017, I have been the Director of the Yale AIDS Program HIV clinical trials program, and a principal investigator on numerous pharmacokinetic, phase 2 and 3 safety and efficacy trials of novel antiviral compounds (HIV, SARS CoV-2). I am also a lead investigator on the international DISCOVER trial evaluating TAF/FTC vs TDF/FTC for HIV prevention among MSM and transgender women as well as PURPOSE-2 trial evaluating long acting lenacapavir for PrEP among MSM, transmasculinizing and transfeminizing individuals as well as gender non binary individuals who have sex with men. I am also funded by NIAID (2023-25) for work advancing HIV PrEP for adolescent girls and young women in Liberia. In response to the COVID pandemic, I have been Yale principal investigator on multiple investigational therapeutic and preventative clinical trials for COVID-19 including remdesivir (now FDA approved), leronlimab and remdesivir and tocilizumab combination therapy as well as the Pfizer/BioNTech and GSK/Sanofi COVID-19 Vaccine trials. IN addition, I am also the PI on multiple ongoing trials evaluating mRNA vaccines for other infectious diseases and vaccines for bacterial infection.